Related Experiment Videos
The learning curve for sentinel node biopsy in malignant melanoma
1Head and Neck Research, Plastic Surgery Unit, Canniesburn Hospital, Bearsden, Glasgow, UK>
British Journal of Plastic Surgery
|August 6, 2002
Summary
Sentinel node biopsy (SNB) is effective for detecting melanoma spread. Improved identification of tumor-containing nodes occurred after initial cases, highlighting a learning curve for this procedure.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel node biopsy (SNB) is a key diagnostic tool for staging cutaneous melanoma.
- Accurate identification of nodal micrometastasis is crucial for treatment planning.
Purpose of the Study:
- To evaluate the learning curve associated with sentinel node biopsy for cutaneous melanoma.
- To compare the effectiveness of SNB in early versus later cases.
Main Methods:
- A retrospective analysis of 60 patients undergoing SNB for cutaneous melanoma.
- Utilized preoperative lymphoscintigraphy, Neoprobe, and Patent Blue V dye for sentinel node identification.
- Compared outcomes between the first 30 and subsequent 30 cases.
Main Results:
- Sentinel nodes were identified in 93% of patients (90% in first 30, 97% in next 30).
- Tumor was found in 21% of sentinel nodes.
- Identification of tumor-containing nodes improved significantly with experience, from 87% (Neoprobe) and 60% (blue dye) in early cases to 100% for both methods in later cases.
- The sentinel node was the only involved node in 71% of patients.
Conclusions:
- Sentinel node biopsy is a feasible and accurate technique for cutaneous melanoma staging.
- A distinct learning curve exists, with improved performance over time.
- The technique requires specialized training and should be performed by experienced practitioners.